|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
564,050,000 |
Market
Cap: |
54.09(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.0959 - $0.0959 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Zomedica is a biopharmaceutical company targeting health and wellness solutions for the companion pet. Co.'s primary drug product candidate is ZM-007, an oral suspension formulation of metronidazole, targeting the treatment of acute diarrhea in small dog breeds and puppies under nine pounds or four kilograms. Co.'s second drug product candidate is ZM-012, a tablet formulation of metronidazole and a complementary formulation to ZM-007, targeting the treatment of acute diarrhea in dogs. Co.'s third drug product candidate is ZM-006, a transdermal gel formulation of methimazole targeting the chronic treatment of hyperthyroidism in cats.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
704,300 |
6,425,290 |
7,575,290 |
9,675,290 |
Total Buy Value |
$32,970 |
$408,354 |
$550,994 |
$876,743 |
Total People Bought |
3 |
9 |
9 |
10 |
Total Buy Transactions |
3 |
13 |
20 |
35 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-04-03 |
2024-12-31 |
2024-07-02 |
2023-07-03 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Blair Anthony K |
COO |
|
2025-05-21 |
4 |
B |
$0.05 |
$4,964 |
D/D |
100,000 |
1,000,000 |
0.01 |
- |
|
Powers Johnny |
|
|
2025-05-19 |
4 |
B |
$0.05 |
$23,000 |
D/D |
500,000 |
3,425,000 |
0.01 |
- |
|
Dehaan-Fullerton Karen |
General Counsel/Corporate Secy |
|
2025-05-19 |
4 |
B |
$0.05 |
$5,006 |
D/D |
104,300 |
104,300 |
0.01 |
- |
|
Rowe Jeffrey M |
|
|
2025-03-17 |
4/A |
B |
$0.06 |
$96,098 |
I/I |
1,439,005 |
2,378,485 |
0.01 |
- |
|
Williams Rodney James |
|
|
2025-03-17 |
4 |
B |
$0.07 |
$6,900 |
D/D |
100,000 |
261,900 |
0.01 |
- |
|
Jordan Scott |
Chief Financial Officer |
|
2025-03-17 |
4 |
B |
$0.06 |
$18,600 |
D/D |
300,000 |
300,000 |
0.01 |
- |
|
Macleod Christopher Ross |
|
|
2025-03-17 |
4 |
B |
$0.06 |
$8,437 |
D/D |
143,000 |
143,000 |
0.01 |
- |
|
Heaton Larry C Ii |
CEO |
|
2025-03-17 |
4 |
B |
$0.05 |
$29,702 |
D/D |
500,000 |
1,000,000 |
0.01 |
- |
|
Klass Russell Kevin |
Sr Vice President of Sales |
|
2025-03-17 |
4 |
B |
$0.07 |
$48,999 |
D/D |
699,980 |
3,200,030 |
0.01 |
- |
|
Rowe Jeffrey M |
|
|
2025-03-17 |
4 |
B |
$0.06 |
$96,098 |
I/I |
1,439,005 |
1,714,005 |
0.01 |
- |
|
Blair Anthony K |
COO |
|
2025-03-17 |
4 |
B |
$0.06 |
$30,000 |
D/D |
500,000 |
900,000 |
0.01 |
- |
|
Williams Rodney James |
|
|
2025-03-17 |
4 |
B |
$0.07 |
$6,900 |
D/D |
100,000 |
100,000 |
0.01 |
- |
|
Powers Johnny |
|
|
2025-03-17 |
4 |
B |
$0.07 |
$33,650 |
D/D |
500,000 |
2,925,000 |
0.01 |
- |
|
Heaton Larry C Ii |
CEO |
|
2024-11-11 |
4 |
B |
$0.12 |
$12,200 |
D/D |
100,000 |
500,000 |
0.01 |
- |
|
Klass Russell Kevin |
Vice President of Sales |
|
2024-11-11 |
4 |
B |
$0.12 |
$60,290 |
D/D |
500,000 |
1,500,050 |
0.01 |
- |
|
Powers Johnny |
|
|
2024-11-11 |
4 |
B |
$0.12 |
$12,100 |
D/D |
100,000 |
2,425,000 |
0.01 |
- |
|
Blair Anthony K |
COO |
|
2024-11-08 |
4 |
B |
$0.12 |
$18,450 |
D/D |
150,000 |
400,000 |
0.01 |
- |
|
Heaton Larry C Ii |
CEO |
|
2024-09-05 |
4 |
B |
$0.13 |
$12,500 |
D/D |
100,000 |
400,000 |
0.01 |
- |
|
Powers Johnny |
|
|
2024-08-28 |
4 |
B |
$0.13 |
$12,900 |
D/D |
100,000 |
2,325,000 |
0.01 |
- |
|
Blair Anthony K |
COO |
|
2024-08-20 |
4 |
B |
$0.14 |
$14,200 |
D/D |
100,000 |
250,000 |
0.01 |
- |
|
Klass Russell Kevin |
Vice President of Sales |
|
2024-06-12 |
4 |
B |
$0.16 |
$46,529 |
D/D |
299,993 |
2,000,050 |
0.01 |
- |
|
Klass Russell Kevin |
Vice President of Sales |
|
2024-06-11 |
4 |
B |
$0.15 |
$75,100 |
D/D |
500,000 |
1,700,057 |
0.01 |
- |
|
Klass Russell Kevin |
Vice President of Sales |
|
2024-06-10 |
4 |
B |
$0.15 |
$29,941 |
D/D |
200,007 |
1,200,057 |
0.01 |
- |
|
Donato Peter |
Chief Financial Officer |
|
2024-06-10 |
4 |
B |
$0.15 |
$3,798 |
D/D |
25,000 |
25,000 |
0.01 |
- |
|
Powers Johnny |
|
|
2024-05-17 |
4 |
B |
$0.17 |
$17,450 |
D/D |
100,000 |
2,225,000 |
0.01 |
- |
|
80 Records found
|
|
Page 1 of 4 |
|
|